Any chance you could elaborate on this- “CU6's continued divergence against its primary target market and geo-graphic benchmarks being S&P500 and NBI is however real.”
Spec bio’s always react strongly to negative(or positive) wider market events. DBX was down 6%, for example. We also have the “sell the news” phenomenon here which has been an ongoing pattern for some time.
I’m not sure what ““divergence” with the NBI you are referring to. Both the NBI and CU6 broke out last week of the downtrend since last year and they both closed the week above the downward resistance. That’s not divergence, that’s lockstep.
CU6 Price at posting:
$2.16 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)